Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxwell D Cummings

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion proteinDirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Journal of Medicinal Chemistry|January 23, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitorÅsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SARDaniel J Parks, Louis V Lafrance, Raul R Calvo, et al.
Journal of Medicinal Chemistry|June 11, 2009
Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymeraseKoen Vandyck, Maxwell D Cummings, Origène Nyanguile, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approachChristoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Angewandte Chemie (International Ed. in English)|February 19, 2010
Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease targetMaxwell D Cummings, Jimmy Lindberg, Tse-I Lin, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2018
Identification and biological evaluation of thiazole-based inverse agonists of RORγtChristian Gege, Maxwell D Cummings, Michael Albers, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitorsOrigène Nyanguile, Frederik Pauwels, Walter Van den Broeck, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1sNalin L Subasinghe, Jeremy M Travins, Farah Ali, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγtChristian Gege, Michael Albers, Olaf Kinzel, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2009
Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion proteinDirk Roymans, Hendrik L De Bondt, Eric Arnoult, et al.
Journal of Medicinal Chemistry|January 23, 2014
Discovery and development of simeprevir (TMC435), a HCV NS3/4A protease inhibitorÅsa Rosenquist, Bertil Samuelsson, Per-Ola Johansson, et al.
Bioorganic & Medicinal Chemistry Letters|January 25, 2005
1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SARDaniel J Parks, Louis V Lafrance, Raul R Calvo, et al.
Journal of Medicinal Chemistry|June 11, 2009
Structure-based design of a benzodiazepine scaffold yields a potent allosteric inhibitor of hepatitis C NS5B RNA polymeraseKoen Vandyck, Maxwell D Cummings, Origène Nyanguile, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2020
Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approachChristoph Steeneck, Christian Gege, Olaf Kinzel, et al.
Angewandte Chemie (International Ed. in English)|February 19, 2010
Induced-fit binding of the macrocyclic noncovalent inhibitor TMC435 to its HCV NS3/NS4A protease targetMaxwell D Cummings, Jimmy Lindberg, Tse-I Lin, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2018
Identification and biological evaluation of thiazole-based inverse agonists of RORγtChristian Gege, Maxwell D Cummings, Michael Albers, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
1,5-benzodiazepines, a novel class of hepatitis C virus polymerase nonnucleoside inhibitorsOrigène Nyanguile, Frederik Pauwels, Walter Van den Broeck, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2006
A novel series of arylsulfonylthiophene-2-carboxamidine inhibitors of the complement component C1sNalin L Subasinghe, Jeremy M Travins, Farah Ali, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2020
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγtChristian Gege, Michael Albers, Olaf Kinzel, et al.
Pageof 6